Access  ||| S:0 E:7 ||| NN
barriers  ||| S:7 E:16 ||| NNS
in  ||| S:16 E:19 ||| IN
early  ||| S:19 E:25 ||| JJ
diagnosis  ||| S:25 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
breast  ||| S:38 E:45 ||| JJ
cancer  ||| S:45 E:52 ||| NN
in  ||| S:52 E:55 ||| IN
the  ||| S:55 E:59 ||| DT
Federal  ||| S:59 E:67 ||| NNP
District  ||| S:67 E:76 ||| NNP
and  ||| S:76 E:80 ||| CC
Oaxaca  ||| S:80 E:87 ||| NNP
To  ||| S:87 E:90 ||| TO
identify  ||| S:90 E:99 ||| VB
social ||| S:99 E:105 ||| JJ
,  ||| S:105 E:107 ||| ,
cultural  ||| S:107 E:116 ||| JJ
and  ||| S:116 E:120 ||| CC
health  ||| S:120 E:127 ||| NN
service  ||| S:127 E:135 ||| NN
barriers  ||| S:135 E:144 ||| NNS
that  ||| S:144 E:149 ||| WDT
prevent  ||| S:149 E:157 ||| VBP
timely  ||| S:157 E:164 ||| JJ
access  ||| S:164 E:171 ||| NN
to  ||| S:171 E:174 ||| TO
early  ||| S:174 E:180 ||| JJ
detection  ||| S:180 E:190 ||| NN
of  ||| S:190 E:193 ||| IN
breast  ||| S:193 E:200 ||| JJ
cancer  ||| S:200 E:207 ||| NN
in  ||| S:207 E:210 ||| IN
two  ||| S:210 E:214 ||| CD
regions ||| S:214 E:221 ||| NNS
:  ||| S:221 E:223 ||| :
Mexico  ||| S:223 E:230 ||| NNP
City  ||| S:230 E:235 ||| NNP
Federal  ||| S:235 E:243 ||| NNP
District  ||| S:243 E:252 ||| NNP
and  ||| S:252 E:256 ||| CC
the  ||| S:256 E:260 ||| DT
state  ||| S:260 E:266 ||| NN
of  ||| S:266 E:269 ||| IN
Oaxaca ||| S:269 E:275 ||| NNP
.  ||| S:275 E:277 ||| .
An  ||| S:277 E:280 ||| DT
exploratory  ||| S:280 E:292 ||| JJ
cross-sectional  ||| S:292 E:308 ||| JJ
qualitative  ||| S:308 E:320 ||| JJ
study  ||| S:320 E:326 ||| NN
was  ||| S:326 E:330 ||| VBD
carried  ||| S:330 E:338 ||| VBN
out  ||| S:338 E:342 ||| RP
in  ||| S:342 E:345 ||| IN
2008  ||| S:345 E:350 ||| CD
among  ||| S:350 E:356 ||| IN
women  ||| S:356 E:362 ||| NNS
under  ||| S:362 E:368 ||| IN
25  ||| S:368 E:371 ||| CD
years  ||| S:371 E:377 ||| NNS
of  ||| S:377 E:380 ||| IN
age  ||| S:380 E:384 ||| NN
without  ||| S:384 E:392 ||| IN
pathology ||| S:392 E:401 ||| NN
,  ||| S:401 E:403 ||| ,
with  ||| S:403 E:408 ||| IN
pathological  ||| S:408 E:421 ||| JJ
diagnosis ||| S:421 E:430 ||| NN
,  ||| S:430 E:432 ||| ,
their  ||| S:432 E:438 ||| PRP$
male  ||| S:438 E:443 ||| JJ
partners  ||| S:443 E:452 ||| NNS
and  ||| S:452 E:456 ||| CC
managers  ||| S:456 E:465 ||| NNS
of  ||| S:465 E:468 ||| IN
several  ||| S:468 E:476 ||| JJ
public  ||| S:476 E:483 ||| NN
and  ||| S:483 E:487 ||| CC
private  ||| S:487 E:495 ||| JJ
institutions ||| S:495 E:507 ||| NNS
.  ||| S:507 E:509 ||| .
Information  ||| S:509 E:521 ||| NNP
was  ||| S:521 E:525 ||| VBD
collected  ||| S:525 E:535 ||| VBN
by  ||| S:535 E:538 ||| IN
focus  ||| S:538 E:544 ||| NN
groups  ||| S:544 E:551 ||| NNS
and  ||| S:551 E:555 ||| CC
through  ||| S:555 E:563 ||| IN
interviews  ||| S:563 E:574 ||| NNS
that  ||| S:574 E:579 ||| WDT
were  ||| S:579 E:584 ||| VBD
recorded  ||| S:584 E:593 ||| VBN
and  ||| S:593 E:597 ||| CC
transcribed  ||| S:597 E:609 ||| NN
after  ||| S:609 E:615 ||| IN
having  ||| S:615 E:622 ||| VBG
received  ||| S:622 E:631 ||| VBN
informed  ||| S:631 E:640 ||| VBN
consent ||| S:640 E:647 ||| NN
.  ||| S:647 E:649 ||| .
Initial  ||| S:649 E:657 ||| JJ
exploration  ||| S:657 E:669 ||| NN
allowed  ||| S:669 E:677 ||| VBD
the  ||| S:677 E:681 ||| DT
identification  ||| S:681 E:696 ||| NN
of  ||| S:696 E:699 ||| IN
access  ||| S:699 E:706 ||| NN
barriers  ||| S:706 E:715 ||| NNS
in  ||| S:715 E:718 ||| IN
three  ||| S:718 E:724 ||| CD
main  ||| S:724 E:729 ||| JJ
areas ||| S:729 E:734 ||| NNS
:  ||| S:734 E:736 ||| :
a ||| S:736 E:737 ||| LS
)  ||| S:737 E:739 ||| -RRB-
the  ||| S:739 E:743 ||| DT
availability  ||| S:743 E:756 ||| NN
of  ||| S:756 E:759 ||| IN
information  ||| S:759 E:771 ||| NN
for  ||| S:771 E:775 ||| IN
the  ||| S:775 E:779 ||| DT
general  ||| S:779 E:787 ||| JJ
population ||| S:787 E:797 ||| NN
,  ||| S:797 E:799 ||| ,
b ||| S:799 E:800 ||| LS
)  ||| S:800 E:802 ||| -RRB-
training  ||| S:802 E:811 ||| NN
of  ||| S:811 E:814 ||| IN
first-contact  ||| S:814 E:828 ||| JJ
general  ||| S:828 E:836 ||| JJ
practitioners  ||| S:836 E:850 ||| NNS
and  ||| S:850 E:854 ||| CC
gynecologists ||| S:854 E:867 ||| NN
,  ||| S:867 E:869 ||| ,
and  ||| S:869 E:873 ||| CC
c ||| S:873 E:874 ||| LS
)  ||| S:874 E:876 ||| -RRB-
fears  ||| S:876 E:882 ||| NNS
among  ||| S:882 E:888 ||| IN
couples  ||| S:888 E:896 ||| NNS
and  ||| S:896 E:900 ||| CC
families ||| S:900 E:908 ||| NNS
.  ||| S:908 E:910 ||| .
Barriers  ||| S:910 E:919 ||| NNS
in  ||| S:919 E:922 ||| IN
the  ||| S:922 E:926 ||| DT
three  ||| S:926 E:932 ||| CD
levels  ||| S:932 E:939 ||| NNS
identified  ||| S:939 E:950 ||| VBN
are  ||| S:950 E:954 ||| VBP
relevant  ||| S:954 E:963 ||| JJ
as  ||| S:963 E:966 ||| IN
they  ||| S:966 E:971 ||| PRP
reveal  ||| S:971 E:978 ||| VBP
important  ||| S:978 E:988 ||| JJ
deficiencies  ||| S:988 E:1001 ||| NNS
in  ||| S:1001 E:1004 ||| IN
the  ||| S:1004 E:1008 ||| DT
dissemination  ||| S:1008 E:1022 ||| NN
of  ||| S:1022 E:1025 ||| IN
information  ||| S:1025 E:1037 ||| NN
both  ||| S:1037 E:1042 ||| CC
to  ||| S:1042 E:1045 ||| TO
the  ||| S:1045 E:1049 ||| DT
general  ||| S:1049 E:1057 ||| JJ
population  ||| S:1057 E:1068 ||| NN
and  ||| S:1068 E:1072 ||| CC
to  ||| S:1072 E:1075 ||| TO
health  ||| S:1075 E:1082 ||| NN
providers ||| S:1082 E:1091 ||| NNS
.  ||| S:1091 E:1093 ||| .
